SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma

Abstract

BackgroundAccumulating evidence has indicated that long non-coding RNAs (lncRNAs) behave as a novel class of transcription products during multiple cancer processes. However, the mechanisms responsible for their alteration in cholangiocarcinoma (CCA) are not fully understood.MethodsThe expression of SPRY4-IT1 in CCA tissues and cell lines was determined by RT-qPCR, and the association between SPRY4-IT1 transcription and clinicopathologic features was analyzed. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays were performed to explore whether SP1 could bind to the promoter region of SPRY4-IT1 and activate its transcription. The biological function of SPRY4-IT1 in CCA cells was evaluated both in vitro and in vivo. ChIP, RNA binding protein immunoprecipitation (RIP) and luciferase reporter assays were performed to determine the molecular mechanism of SPRY4-IT1 in cell proliferation, apoptosis and invasion.ResultsSPRY4-IT1 was abnormally upregulated in CCA tissues and cells, and this upregulation was correlated with tumor stage and tumor node metastasis (TNM) stage in CCA patients. SPRY4-IT1 overexpression was also an unfavorable prognostic factor for patients with CCA. Additionally, SP1 could bind directly to the SPRY4-IT1 promoter region and activate its transcription. Furthermore, SPRY4-IT1 silencing caused tumor suppressive effects via reducing cell proliferation, migration and invasion; inducing cell apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) process in CCA cells. Mechanistically, enhancer of zeste homolog 2 (EZH2) along with the lysine specific demethylase 1 (LSD1) or DNA methyltransferase 1 (DNMT1) were recruited by SPRY4-IT1, which functioned as a scaffold. Importantly, SPRY4-IT1 positively regulated the expression of EZH2 through sponging miR-101-3p.ConclusionsOur data illustrate how SPRY4-IT1 plays an oncogenic role in CCA and may offer a potential therapeutic target for treating CCA.Electronic supplementary materialThe online version of this article (10.1186/s13046-018-0747-x) contains supplementary material, which is available to authorized users.

Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR‐1238

“…It is well known that some long noncoding RNAs (lncRNAs) functions as a "sponge" to absorb downstream miRNAs at posttranscriptional level. 21 Similarly, circRNAs could also sponge miRNAs to regulate target genes expression. 22,23 For example, Xie et al revealed that circRNA BCRC-3 suppresses bladder cancer cell growth via the miR-182-5p/p27 signaling pathway.…”

Up‐regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR‐296‐5p

“…Cholangiocarcinoma cell lines (CCLP‐1, RBE, QBC939 and HuCCT1) and normal control cell line HIBEC were preserved in the laboratory as previously described . Cells were cultured in 10% foetal bovine serum (FBS) loaded RPMI‐1640 medium (Invitrogen Life Technologies) and 100 μg/mL penicillin/streptomycin supplemented at 37°C with 5% CO 2 in a humidified incubator.…”

“…Tumour growth measurement was performed every 72 hours from the sixth day. The calculation for tumour volumes, euthanization, mice weight measurement and xenografts RNA evaluation were conducted as previously described …”

Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway

“…Cell metastatic properties were determined by Transwell assays in accordance with the previous studies [14,17].…”

“…The xenograft study was approved by the Animal Care and Use Committee of Harbin Medical University and conducted as previously described [14,17]. Transfected MCF7 cells were used for injection.…”